Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 120 diseases. https://garudatx.com
Company Details
- Employees
- 20
- Founded
- 2021
- Address
- Cambridge, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://garudatx.com
- Keywords
- hsc, stem cells, ipsc, research and development, start-up, biotech, cell therapy, gene therapy, cell and gene therapy, platform, manufacturing, cell therapy manufacturing, blood diseases, hematologic malignancies, sickle cell disease, beta thalassemia, bone marrow failure disease, clinical trials, clinical, pluripotent stem cells.
- HQ
- Cambridge, MA
Garuda Therapeutics Questions
Garuda Therapeutics's website is https://garudatx.com
Garuda Therapeutics's LinkedIn profile is https://www.linkedin.com/company/garuda-therapeutics
Garuda Therapeutics has
20 employees.
View email and phone details for 20
employees at Garuda Therapeutics.
Garuda Therapeutics's industry is
Biotechnology Research
Garuda Therapeutics's top competitors are
Stellaromics Inc.,
Pledge Therapeutics,
Nona Biosciences,
Marengo Therapeutics,
Scismic,
Incendia Therapeutics,
Oddity Labs,
Manifold Bio,
Stylus Medicine,
Qld Biotherapeutics Inc.
Garuda Therapeutics's categories are Biotechnology Research
Garuda Therapeutics's founding year is 2021
